Aim-To determine the extent of liver damage resulting from infection with hepatitis B, C and D viruses (HBV, HCV and HDV) (i Clin Pathol 1996;49:552-555) 
Hepatitis virus infection and liver disease in injecting drug users who died suddenly The cause of death on the necropsy report was drug intoxication in 34 subjects. Other causes of death were hanging (two subjects), stabbing, congenital heart disease, hypertensive heart disease, myocardial fibrosis, myocarditis, hernia of small bowel, bacterial endocarditis, bronchitis and cirrhosis of liver, polycystic kidneys, and epileptiform seizure. Cause of death was not ascertained in one subject and reports were not available for two. Drugs detected postmortem were morphine (n = 24), benzodiazepines (n = 23), ethyl alcohol (n =17), paracetamol (n = 5), cannabis (n = 2), and diconal, prothiaden, chloral hydrate, cyclizine, and methadone (n = 1 for each drug). More than one drug was present in 30 subjects.
All serum samples were tested for current or past infection with HCV, HBV or HIV by assays for antibodies directed against these agents and for HBsAg. In those subjects positive for the latter, tests for the stage and infectivity of the HBV infection and for superinfection with HDV were performed. Reverse transcription-polymerase chain reaction (RT-PCR) for HCV RNA was carried out on all serum samples for which sufficient sample remained.
Serum samples were examined for antibodies directed against HCV by a second generation enzyme linked immunosorbent assay Tables 2 and 3 show the combined results of HCV and HBV testing. Of 33 serum samples with current or past evidence of HBV infection, 32 (97%) were positive for anti-HCV. Six subjects positive for anti-HCV had no evidence of past exposure to HBV. The one HIV positive serum contained no anti-HCV, anti-HBc or anti-HBs, but was positive for HCV by RT-PCR. The second anti-HCV negative serum which was positive by RT-PCR had evidence of past HBV infection. Therefore, in this series, there was no subject with evidence of current or past HBV infection in the absence of HCV infection.
HISTOPATHOLOGY
Of the 48 livers were included in the study, two could not be scored for necroinflammatory Only five livers were histologically within normal limits although, in two of these, autolysis prevented the assessment of inflammatory infiltration. All remaining 43 livers showed abnormal liver histology, with a chronic inflammatory infiltrate present within at least some portal tracts. In many, the infiltrate was patchy, often varying considerably in intensity between portal tracts. Portal lymphoid follicles were observed in only two livers. In 13 subjects, lobular inflammation accompanied by parenchymal cell necrosis was noted; bridging necrosis was observed in six of these. Portal or periportal fibrosis, or both, was present in 15 subjects. In three of these, there was accompanying architectural distortion, which amounted to cirrhosis in two. Non-caseating granulomas were identified in two livers. Although no aetiological agent could be identified in either, they were presumed to be related to intravenous drug use. In none of the livers examined was there any evidence of toxic (including alcohol induced) damage. Tables 2 and 3 show the relation between the serological results for hepatitis B and C and necroinflammatory activity and fibrosis scores, respectively. Subjects were considered to have HCV infection if their serum contained anti-HCV or HCV RNA, or both. All HCV infected livers had a necroinflammatory score of i 1 and fibrosis was seen in 15 (35%) of 43.
CORRELATION OF SEROLOGY WITH HISTOPATHOLOGY
None of the uninfected livers showed any inflammation or fibrosis. The association between HCV infection and inflammatory score was significant by Fisher's exact test (p < 0.0001 for the whole study group; p < 0.008 for the subset with no evidence of past or present HBV infection).
Considering livers from HCV positive intravenous drug users, there was nothing to indicate that either past or current HBV infection, in the absence of HDV superinfection, had any effect on the scores for necroinflammatory activity (p = 0.68) or fibrosis (p = 0.57). In contrast, the three livers from HDV superinfected carriers had either severe architectural distortion or cirrhosis, and had high scores of 2,3 and 3, respectively, for necroinflammatory activity.
Discussion
Serological evidence of infection with blood borne viruses was common in this group of intravenous drug users who died suddenly. HCV was the most prevalent with 43 (90%) serum samples containing HCV RNA or anti-HCV. All six (12%) HBsAg positive serum samples had markers indicative of chronic HBsAg carriage and three were superinfected with HDV. Evidence of past infection was found in 28 (70%) HBsAg negative serum samples available for testing. Anti-HIV was detected in one (2%) sample. In only five (10%) serum samples was there no evidence of current or past infection with HCV, HBV or HIV. When an individual starts sharing needles in a group of drug users, he is more likely to be exposed to blood containing infectious HCV than HBV. As HCV RNA was detected in 17 of those that could be tested, a minimum rate of current infection is 41% in this population. Glasgow are infected with HCV in their teens and twenties. There was no evidence from our study that liver damage was more severe in HCV positive subjects where there was evidence of current or past infection with HBV.
In conclusion, of 48 intravenous drug users who died suddenly, HCV infection was found in 43 (90%), current HBV in six (11%) and HIV in one (2%). Liver disease was mild in intravenous drug users with evidence of current HCV infection alone. Severe hepatic architectural distortion was seen only in those with concurrent HBV, D and C infections. 
